Effects of granulocyte-colony stimulating factor on bone marrow-derived progenitor cells in murine cardiac transplantation

Cardiovascular Pathology

Volumn 19, Issue 1, 2010, Pages 36-47

  Rezai, Nana ^a   Deisher, Theresa A ^b   Heine, Heather L ^a   Wang, Xiaozhen ^b   Corbel, Stephane Y ^c   Leung, Joanna ^a   Kerjner, Alexandra ^a   Rossi, Fabio M V ^c   Podor, Thomas J ^a   McManus, Bruce M ^a  

^a The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research   (Canada)

^b AMGEN INC   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Bone marrow; G CSF; Heart; Stem cell; Transplantation

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS;

ALLOGRAFT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA INTIMA; APOPTOSIS; ARTICLE; BLOOD VESSEL; BONE MARROW; CELL COUNT; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; HOST CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL SEPARATION; CORONARY VESSELS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; NEOVASCULARIZATION, PHYSIOLOGIC; TACROLIMUS;

EID: 70849112973     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2008.10.007     Document Type: Article

References (34)

1. Egi H., Hayamizu K., Ohmori I., Kitayama T., and Asahara T. Upregulation of intragraft interleukin-10 by infusion of granulocyte colony-stimulating factor-mobilized donor leukocytes. Transpl Int 15 9-10 (2002) 479-485
2. Hayamizu K., Yahata H., Shinozaki K., Tanji H., Strober S., and Asahara T. Granulocyte colony-stimulating factor-mobilized donor monocytes facilitate heart allograft acceptance. Transplant Proc 32 7 (2000) 2068-2069
3. Hayamizu K., Egi H., Ohmori I., Kitayama T., and Asahara T. Improvement of heart allograft acceptability by pretreatment of donors with granulocyte colony-stimulating factor. Transplant Proc 34 7 (2002) 2732
4. Morstyn G., Lieschke G.J., Cebon J., Duhrsen U., Villeval J.L., Sheridan W., et al. Early clinical trials with colony-stimulating factors. Cancer Invest 7 5 (1989) 443-456
5. Bhattacharya V., Shi Q., Ishida A., Sauvage L.R., Hammond W.P., and Wu M.H. Administration of granulocyte colony-stimulating factor enhances endothelialization and microvessel formation in small-caliber synthetic vascular grafts. J Vasc Surg 32 1 (2000) 116-123
6. Kong D., Melo L.G., Gnecchi M., Zhang L., Mostoslavsky G., Liew C.C., et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 110 14 (2004) 2039-2046
7. Elfenbein G.J. Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose?. Pediatr Transplant 9 7 Suppl (2005) 37-47
8. Kalka C., Masuda H., Takahashi T., Gordon R., Tepper O., Gravereaux E., et al. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86 12 (2000) 1198-1202
9. Shi Q., Bhattacharya V., Hong-De Wu M., and Sauvage L.R. Utilizing granulocyte colony-stimulating factor to enhance vascular graft endothelialization from circulating blood cells. Ann Vasc Surg 16 3 (2002) 314-320
10. Powell T.M., Paul J.D., Hill J.M., Thompson M., Benjamin M., Rodrigo M., et al. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 25 2 (2005) 296-301
11. Wright D.E., Cheshier S.H., Wagers A.J., Randall T.D., Christensen J.L., and Weissman I.L. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood 97 8 (2001) 2278-2285
12. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98 18 (2001) 10344-10349
13. Takagi Y., Omura T., Yoshiyama M., Matsumoto R., Enomoto S., Kusuyama T., et al. Granulocyte-colony stimulating factor augments neovascularization induced by bone marrow transplantation in rat hindlimb ischemia. J Pharmacol Sci 99 1 (2005) 45-51
14. Rezai N., Corbel S.Y., Dabiri D., Kerjner A., Rossi F.M., McManus B.M., et al. Bone marrow-derived recipient cells in murine transplanted hearts: potential roles and the effect of immunosuppression. Lab Invest 85 8 (2005) 982-991
15. Corbel S.Y., Lee A., Yi L., Duenas J., Brazelton T.R., Blau H.M., et al. Contribution of hematopoietic stem cells to skeletal muscle. Nat Med (2003)
16. Rezai N., Walinski H., Kerjner A., Bohunek L., Rossi F.M., McManus B.M., et al. Methods for examining stem cells in post-ischemic and transplanted hearts. Methods Mol Med 112 (2005) 223-238
17. Armstrong A.T., Strauch A.R., Starling R.C., Sedmak D.D., and Orosz C.G. Morphometric analysis of neointimal formation in murine cardiac allografts. Transplantation 63 7 (1997) 941-947
18. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 4 (2001) 430-436
19. Pan L., Delmonte Jr. J., Jalonen C.K., and Ferrara J.L. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 86 12 (1995) 4422-4429
20. Lu C.Y., Sicher S.C., and Vazquez M.A. Prevention and treatment of renal allograft rejection: new therapeutic approaches and new insights into established therapies. J Am Soc Nephrol 4 6 (1993) 1239-1256
21. Groth C.G., Backman L., Morales J.M., Calne R., Kreis H., Lang P., et al. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation 67 7 (1999) 1036-1042
22. Kahan B.D., Podbielski J., Napoli K.L., Katz S.M., Meier-Kriesche H.U., and Van Buren C.T. Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation. Transplantation 66 8 (1998) 1040-1046
23. Kelly P.A., Gruber S.A., Behbod F., and Kahan B.D. Sirolimus, a new, potent immunosuppressive agent. Pharmacotherapy 17 6 (1997) 1148-1156
24. Arpinati M., Green C.L., Heimfeld S., Heuser J.E., and Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95 8 (2000) 2484-2490
25. Mielcarek M., Graf L., Johnson G., and Torok-Storb B. Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 92 1 (1998) 215-222
26. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107 9 (2003) 1322-1328
27. Petit I., Szyper-Kravitz M., Nagler A., Lahav M., Peled A., Habler L., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3 7 (2002) 687-694
28. Moore M.A., Hattori K., Heissig B., Shieh J.H., Dias S., Crystal R.G., et al. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann N Y Acad Sci 938 (2001) 36-45 [discussion -7]
29. Hiasa K., Ishibashi M., Ohtani K., Inoue S., Zhao Q., Kitamoto S., et al. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 109 20 (2004) 2454-2461
30. Rafii S., Heissig B., and Hattori K. Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther 9 10 (2002) 631-641
31. Wright D.E., Bowman E.P., Wagers A.J., Butcher E.C., and Weissman I.L. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med 195 9 (2002) 1145-1154
32. Yamani M.H., Ratliff N.B., Cook D.J., Tuzcu E.M., Yu Y., Hobbs R., et al. Peritransplant ischemic injury is associated with up-regulation of stromal cell-derived factor-1. J Am Coll Cardiol 46 6 (2005) 1029-1035
33. Oguma K., Sano J., Kano R., Watari T., Moritomo T., and Hasegawa A. In vitro effect of recombinant human granulocyte colony-stimulating factor on canine neutrophil apoptosis. Vet Immunol Immunopathol 108 3-4 (2005) 307-314
34. Basu S., Hodgson G., Katz M., Dunn A.R., Oguma K., Sano J., et al. Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation. In vitro effect of recombinant human granulocyte colony-stimulating factor on canine neutrophil apoptosis. Blood 100 3 (2002) 854-861